Martine A Rothblatt sold $4.6M of United Therapeutics (UTHR)

Executed Sep 18, disclosed Sep 21, 3 days later.

Value, as filed

$4.6M

9,340 sh across 5 lots

Executed

Sep 18

the trade date, as filed

Disclosed

Sep 21

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Martine A Rothblatt Chairperson & CEO profile →

Martine A Rothblatt (Chairperson & CEO) filed 169 Form 4 reports in the trailing twelve months (0 purchases, 169 sales, 2 filed past the two-business-day deadline), most often in United Therapeutics Corporation (UTHR). The largest single filing was $10.9M of UTHR (18,840 sh across 15 lots, as filed), executed Apr 14.

The name

UTHR

United Therapeutics Corporation UTHR · Healthcare · 343 filings in 24 months ticker →

Healthcare · United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Martine A Rothblatt in UTHR

UTHRSALE United Therapeutics Corporation $4.6M
9,189 sh across 7 lots
Exec Sep 17
Filed Sep 18 · 4:41 PM ET UTHRSALE United Therapeutics Corporation $4.7M
9,380 sh across 7 lots
Exec Sep 16
Filed Sep 17 · 4:43 PM ET UTHRSALE United Therapeutics Corporation $4.8M
9,500 sh across 5 lots
Exec Sep 14
Filed Sep 15 · 4:34 PM ET UTHRSALE United Therapeutics Corporation $4.7M
9,418 sh across 11 lots
Exec Sep 11
Filed Sep 14 · 4:43 PM ET UTHRSALE United Therapeutics Corporation $4.7M
9,380 sh across 9 lots
Exec Sep 10
Filed Sep 11 · 4:34 PM ET UTHRSALE United Therapeutics Corporation $4.6M
9,260 sh across 12 lots
Exec Sep 9
Filed Sep 10 · 4:31 PM ET UTHRSALE United Therapeutics Corporation $4.5M
8,976 sh across 11 lots
Exec Sep 8
Filed Sep 9 · 4:33 PM ET UTHRSALE United Therapeutics Corporation $4.6M
9,460 sh across 6 lots
Exec Sep 4
Filed Sep 8 · 4:31 PM ET